N/A
Completed N=15
Yoga in Adult Cancer: A Feasibility Trial
Source: ClinicalTrials.gov NCT02309112 ↗Enrolled (actual)
15
Serious AEs
0.0%
Results posted
Feb 2015
Primary outcomePrimary: Feasibility of Patient Recruitment to Yoga Intervention — 15; 1.5 participants
Summary
A feasibility study to determine the appropriateness of yoga intervention to improve health-related quality of life in adult cancer patients.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of Patient Recruitment to Yoga Intervention |
15; 1.5 | — |
| SECONDARY Patient Adherence to Yoga Intervention |
4; 5; 4 | — |
| SECONDARY Patient Adherence Rate to Yoga Intervention |
80; 100; 80 | — |
Eligibility Criteria
Inclusion Criteria
- Male and female adult cancer patients 19 years of age or older
- Patients receiving or planning to receive conventional treatment that includes at least one of chemotherapy, radiotherapy, hormone therapy or active surveillance within 28 days
- Patients in any stage of cancer diagnoses of all tumour types and locations
- Participants with internet access and willingness to participate in online communication
- Participants with access to transportation and personal willingness to attend meetings in central Vancouver, Canada.
- Participants fluent in the English language
Exclusion Criteria
- Patients with any physical limitation, risk of personal injury or under proscription of light to moderate physical activity
- Patients with pre or post surgical interventions were excluded due to potential physical limitations or safety concerns with wound healing
- Regular or experienced practitioners of yoga were excluded and defined as those patients reporting current or historical use of regular yoga (>2 session per month in past 12 months)
- Patients undergoing medical treatment for serious psychological disturbances that might have interfered with adherence to protocol and/or ability to provide informed consent were excluded (e.g. multiple personality disorders, severe depression, obsessive-compulsive disorder)
Data sourced from ClinicalTrials.gov (NCT02309112). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.